Sponsors (17)
The bill mandates a rapid, detailed federal review of veteran suicides that promises better-targeted prevention, transparency, and research data but raises significant privacy, operational, cost, and reputational risks that must be managed.
Veterans (and their families): a mandated, comprehensive federal review of veteran suicides will identify patterns, risk factors (including combat, MST, TBI, PTSD) and enable targeted prevention and trauma‑informed care reforms.
VA facilities and clinicians: the review will identify facilities with unusually high prescription and suicide rates so they can receive targeted quality reviews and corrective actions.
Patients, families, researchers, and policymakers: public release of review findings within 30 days increases transparency and speeds access to information for affected families, researchers, and decisionmakers.
Veterans, VA staff, and health systems: publishing granular medication, diagnosis, and facility data risks exposing sensitive patient information if de‑identification is inadequate.
VA staff and hospitals: completing an extensive, detailed review within 18 months may strain VA personnel and resources and divert time from clinical care.
Taxpayers and VA budgets: the review will require additional administrative funding or reallocation of VA resources, imposing costs on taxpayers or other VA programs.
Based on analysis of 2 sections of legislative text.
Requires the VA to complete and publicly release an 18‑month review of suicide deaths among veterans who used VA care in the prior five years, with detailed medication, diagnosis, facility, and demographics analysis.
Requires the VA Secretary to complete a public review within 18 months of enactment of suicide deaths among veterans who used VA hospital care or medical services during the five years before their death. The review must count suicides, summarize demographics and clinical diagnoses, list medications prescribed or detected (flagging risky drug categories and polypharmacy), identify VHA facilities with high prescribing and suicide rates, describe VA prescribing policies, identify apparent patterns, and give recommendations; the report must be submitted to Congress and publicly released within 30 days of completion.
Official title: To direct the Secretary of Veterans Affairs to conduct a review of the deaths of certain veterans who died by suicide, and for other purposes.
Introduced December 18, 2025 by Andrew R. Garbarino · Last progress December 18, 2025